Ingredient Safety

Senators Dick Durbin (D-Ill.) and Bill Cassidy, M.D. (R-La.) recently introduced legislation to combat the online sale of stolen, counterfeit, and dangerous consumer products by ensuring transparency of high-volume third-party sellers in online retail marketplaces.

In a new letter, ACI and CHPA call on FDA to withdraw its temporary guidance for the manufacturing of alcohol-based hand sanitizer products.

CHPA is set to testify on Monday before the Massachusetts Joint Committee on Public Health. The hearing, which will be held virtually, is the first policy committee hearing for the Commonwealth’s legislature in 2021. Nearly 50 bills are scheduled to be considered during the hearing, including four bills on which CHPA will be testifying.

CHPA released the following statement in response to FDA’s warning that consumers avoid certain male enhancement and weight loss products sold by major online retailers due to hidden, potentially dangerous drug ingredients.

Today’s column in the Los Angeles Times is aligned with calls from responsible manufacturers in the dietary supplement industry who agree that regulations need to be modernized and strengthened.

CHPA released the following statement in response to ongoing efforts by the U.S. Food and Drug Administration (FDA) to keep hand sanitizers that contain harmful substances off the market.

OTC manufacturers share FDA’s commitment to providing consumers with products that are safe and effective.

Medical and patient groups, public health experts, FDA, and others join the Consumer Healthcare Products Association in opposing the addition of acetaminophen to the Proposition 65 list.